Industry Articles

 California Calls on Laboratories to Speed Up Test Processing for Most At-Risk Group

July 4, 2020

As state hits record number of tests, California asks labs to prioritize testing turnaround for individuals who are most at risk of spreading virus to others.

 Changes to California Code of Regulations, title 17, section 2505, Reportable Conditions: Notification by Laboratories, effective October 1, 2019 (PDF)

On March 9, 2020, the list of reportable diseases in Title 17, California Code of Regulations (17 CCR) section 2500 was amended to include COVID-19 and Novel coronavirus infections, and 17 CCR section 2505 was amended to include SARS-CoV-2 and Coronavirus, novel strains, effective immediately. On July 28, 2020, the reporting regulations at 17 CCR section 2500 and 2505 were amended to change reporting times and require additional patient information. This link provides more information, including links to the updated sections listing reportable diseases and conditions, as well as new requirements for reporting results for SARS-CoV-2 testing.

 CalREDIE Guidance Document for 17 CCR section 2505, September 2019 (PDF)

This The CDPH Division of Communicable Disease Control recently updated Section 2505 of Title 17 of the California Code of Regulations, which specifies laboratory reporting requirements for communicable diseases and conditions. This guidance document provides information about submitting reports through the California Reportable Disease Information Exchange - Electronic Lab Reporting (CalREDIE ELR) system.

 Reportable Diseases and Conditions

May 28, 2019

Specified diseases and conditions are mandated by State laws and regulations to be reported by healthcare providers and laboratories to the public health authorities.

 Mobile Health Screenings

July 11, 2018

There are two different types of mobile health screenings allowed under state law, each having specific requirements. Regardless of type, consumers should be aware of the risks and limitations involved, and should exercise due diligence and caution.

 Non-Compliance Inducement Letter (PDF)

May 2018

Notice regarding non-compliance inducement in physicians’ offices will be presented at the May 2018 CLTAC meeting.

 CDC’s Health Advisory – May 17, 2017

A CDC health advisory has been issued May 17, 2017 regarding potential for falsely low blood lead test results from LeadCare® Analyzers.